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During the cancerous transformation of normal hepatocytes into hepatocellular carcinoma
(HCC), the enzyme catalyzing the first rate-limiting step of glycolysis, namely the glucokinase
(GCK), is replaced by the higher affinity isoenzyme, hexokinase 2 (HK2). Here, we show that
in HCC tumors the highest expression level of HK2 is inversely correlated to GCK expression,
and is associated to poor prognosis for patient survival. To further explore functional con-
sequences of the GCK-to-HK2 isoenzyme switch occurring during carcinogenesis, HK2
was knocked-out in the HCC cell line Huh7 and replaced by GCK, to generate the Huh7-
GCK+/HK2− cell line. HK2 knockdown and GCK expression rewired central carbon meta-
bolism, stimulated mitochondrial respiration and restored essential metabolic functions of
normal hepatocytes such as lipogenesis, VLDL secretion, glycogen storage. It also reactivated
innate immune responses and sensitivity to natural killer cells, showing that consequences of
the HK switch extend beyond metabolic reprogramming.
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Hepatocellular carcinoma (HCC) is the most common livercancer and the fourth leading cause of cancer-relateddeath1. HCC is closely linked to chronic liver inflamma-
tion, chronic viral hepatitis, exposure to toxins, and metabolic
dysfunction such as non-alcoholic steatohepatitis (NASH). HCC
is of poor prognosis, and treatments are essentially based on
surgical resection, liver transplantation or aggressive chemo and/
or radiotherapy. In patients with advanced HCC, broad-spectrum
kinase inhibitors are approved2 but with limited benefit3. Effec-
tive personalized therapies are needed but their development is
impeded by our poor understanding of molecular mechanisms
underlying HCC onset and progression. Efforts to characterize
the disease on the basis of etiology and outcomes revealed
metabolic deregulation as a hallmark of HCC progression4.
Indeed, metabolic remodeling is critically required for tumor
growth, since bioenergetic requirements and anabolic demands
drastically increase5–7. For instance, HCC cells have lost their
ability to secrete very low-density lipoproteins (VLDL), a highly
specialized function of hepatocyte and can only secrete low-
density lipoproteins (LDL)-like lipoproteins, indicating a defec-
tive lipogenesis and/or lipoprotein assembly8.
Metabolic reprogramming in cancer cells involves the mod-
ulation of several enzymes by oncogenic drivers6. Targeting these
enzymes is now considered as a therapeutic strategy for several
types of cancers6. Among these enzymes, hexokinase 2 (HK2)
stands out because of its elevated or induced expression in
numerous cancers, including HCC9. Hexokinases control the first
rate-limiting step of glucose catabolism by phosphorylating glu-
cose to glucose-6-phosphate (G6P), fueling glycolysis as well as
glycogen, pentose phosphate and triglyceride synthesis. The
human genome contains four genes encoding distinct hexokinase
isoenzymes, named HK1 to HK4 (HK4 is also known as gluco-
kinase or GCK), with distinct enzymatic kinetics and tissue dis-
tributions. A fifth putative hexokinase enzyme was recently
discovered but has not been fully characterized yet10. A switch
from GCK to HK2 isoenzymes is occurring during the transition
from primary to tumor hepatocytes so that HCC cell lines express
HK2 but no longer GCK. HK2 expression level has been corre-
lated with disease progression and dedifferentiation of HCC
cells11. When HK2 is artificially knocked-down in HCC cell lines,
glycolysis is repressed, and tumorigenesis is inhibited while cell
death increases9. In addition, hexokinase function extends
beyond metabolism towards autophagy, cell migration, and
immunity, suggesting that the GCK-to-HK2 isoenzyme switch
has broader consequences than initially suspected12–15. Here, we
analyzed transcriptomic data of HCC biopsies and correlated
hexokinase isoenzyme expression level with patient survival. This
led us to generate a new cellular model of human HCC expressing
GCK instead of HK2. A comparative analysis of GCK+ vs HK2+
HCC cell lines provided a unique opportunity to look into HK
isoenzyme-dependent metabolic features, lipoprotein production
and resistance to immune signals of liver cancer cells.
Results
Relative expression level of GCK and HK2 in HCC patients.
Although an isoenzyme switch from GCK to HK2 has been
observed during the carcinogenesis process16, whether hexokinase
isoenzymes expression is predictive of patient survival is unclear.
We first analyzed the transcriptomes (RNA-seq data) of 365 HCC
biopsies from The Cancer Genome Atlas (TCGA) database17,18
(Supplementary Data 1). For each HK, the individual gene
expression level was used to stratify patients into two subgroups
according to Uhlen et al.18 and overall survival in the two sub-
groups was determined using a Kaplan-Meier’s estimator.
Although HK1 or HK3 expression level were not associated to
patient survival rate (Fig. 1a), highest expression levels of HK2 as
previously described19 and lowest expression levels of GCK in the
tumors were associated with a lower survival rate. We thus
stratified patients based on the GCK/HK2 expression ratio to
combine these two markers (Fig. 1b). When patients were stra-
tified on the basis of HK2 or GCK expression levels, the median
survival between the corresponding subgroups differed by 33.8
and 36.5 months, respectively (Fig. 1a). This difference reached
42.8 months when the stratification of patients was based on the
GCK/HK2 ratio (Fig. 1b). This demonstrated that the GCK/HK2
ratio outperforms HK2 or GCK expression alone as predictor of
patient survival. Finally, correlation coefficients between patient
survival in months and HK2 or GCK expression level were
determined. For this, we only considered the subset of 130
patients for whom the period between diagnosis and death is
precisely known (uncensored data), and performed a Spearman’s
rank correlation test (Fig. 1c). Patient survival was positively
correlated to GCK expression but inversely correlated to HK2
expression in line with the Kaplan-Meier analysis. In addition,
GCK and HK2 expression tends to be inversely correlated in
tumor samples (Fig. 1c). Therefore, there is a trend for mutual
exclusion of GCK and HK2 expression in HCC tumors, and this
profile is associated to clinical outcome.
Engineering a cellular model of the hexokinase isoenzyme switch.
To decipher functional consequences of GCK or HK2 expression in
a HCC model, we restored GCK expression by lentiviral transduc-
tion in the reference HCC cell line Huh7, and knocked-out the
endogenous HK2 gene by CRISPR/Cas9. The exclusive expression of
HK2 and GCK in Huh7 and Huh7-GCK+/HK2− cell lines,
respectively, was validated, while HK1 and HK3 were not expressed
(Fig. 2a and Supplementary Fig. 1). The hexokinase activity in the
presence of increasing concentration of glucose was determined in
protein lysates from the two respective cell lines. Hexokinase activity
in Huh7 lysate reached its maximum at low glucose concentration,
presenting a saturation curve according to Michaelis–Menten
kinetics (Fig. 2b). In contrast, the hexokinase activity in Huh7-
GCK+/HK2− lysates followed a pseudo-allosteric response to glu-
cose20,21. Thus, the expected HK2 and GCK activities were observed
in the Huh7 and Huh7-GCK+/HK2− cells respectively. The cell
proliferation capacity remained identical between the two cell lines
(Supplementary Fig. 2). We then compared the genome edited
Huh7-GCK+/HK2− and the parental Huh7 cell lines at a tran-
scriptomic, metabolic and immunological level.
Transcriptomic data revealed extended modifications of
metabolic connections in Huh7-GCK+/HK2−. Transcriptomic
profiles of Huh7 and Huh7-GCK+/HK2− cells were determined
by next generation sequencing (Supplementary Data 2). Overall,
4.2% of the gene transcripts were reduced and 6.9% were induced
in Huh7-GCK+/HK2− compared to Huh7 (Fig. 2c; | fold-change
(FC) | > 2 and p value<0.05). We first determined the metabolic
consequences of the HK isoenzyme switch by mapping the dif-
ferentially expressed genes onto the well-established bipartite
metabolic network Recon2, connecting gene products and
metabolites (Supplementary Figs. 3–5)22,23. After trimming
highest-degree metabolites as currency metabolites, clusters of
genes that are both differentially expressed and connected by
common metabolites emerged. Interestingly, we found that across
a wide range of analysis parameters, including varying rates of
currency metabolites and gene expression fold-change, the dif-
ferentially expressed metabolic genes are substantially better
connected than expected by chance (Fig. 2d). This highlights the
specificity of the transcriptomic changes with respect to metabolic
pathways. The spanned network presented in Fig. 2e corresponds
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to a stringent fold-change threshold for transcriptomic data
(log2(| FC |) > 3) while removing 2 percent of highest-degree
currency metabolites. This network shows connected components
within glycolysis, but also across distant modules including the
gamma-aminobutyric acid (GABA) shunt (ALDH5A1), urea
cycle (CPS1, OTC), glycogen metabolism (GYS1, GYS2, AGL)
and lipid synthesis (GPAM, AGPAT4, DGKG, CDS1, A4GALT)
or degradation (ACADL, HSD17B4, AMACR). This analysis
highlights the global impact of the HK isoenzyme switch that
spreads beyond glycolysis across distant connected metabolic
modules.
Enrichment of molecular and cellular functions in differentially
expressed genes was also analyzed using Ingenuity Pathway
Analysis (IPA). This revealed that cellular movement and lipid
metabolism were the most affected functions (Table 1 and
Supplementary Data 3). A closer look at these annotations
Fig. 1 Correlation between hexokinase expression levels in HCC tumors and patient survival. a Kaplan–Meier estimates of the survival of HCC patients
depending on the expression of HK1, HK2, HK3 and GCK (HK4) genes in tumor biopsies (n= 365; diploid samples; TCGA expression data retrieved from
cBioPortal; Firehose Legacy)74,75. Duplicate analyses from the same patient were removed as well as patients who died when biopsied (overall
survival=0 months or not specified). Optimal stratification based on highest and lowest gene expression values was determined using Protein Atlas
database18. b Same as above but patients were stratified based on the GCK/HK2 gene expression ratio. The stratification showing the lowest p value when
comparing subgroups of patients with the highest to the lowest GCK/HK2 expression ratio is displayed. Patient TCGA-DD-AAE9 exhibiting undetectable
levels of GCK and HK2 was removed from this analysis as the GCK/HK2 ratio could not be calculated. c Correlations between patient survival, GCK
expression and HK2 expression. Spearman’s rank correlation test on the subset 130 patients for whom the period between diagnosis and death is precisely
known (uncensored data).
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pointed to differences in the migratory capacities (Table 2) as well
as lipid concentration and synthesis (Table 3). The migratory
capacities of Huh7 and Huh7-GCK+/HK2− were compared using
transwell-migration cell assays (Fig. 3a, b). Results showed a
higher migratory capacity of Huh7-GCK+/HK2− cells, in line
with Kishore M. et al showing that GCK expression induced
by pro-migratory signals controls the trafficking of CD4+/CD25+
/FOXP3+ regulatory T (Treg) cells15. To validate the differences in
lipid metabolism highlighted by the transcriptomic analysis,
intracellular content in neutral lipids was first determined with
lipophilic dyes. As assessed by Oil-Red-O or BODIPY staining, an
accumulation of intracellular neutral lipids was observed in
Huh7-GCK+/HK2− in comparison to Huh7 (Fig. 3c, d). The
accumulation of neutral lipids in Huh7 expressing both HK2 and
GCK indicates that the phenotype is driven by GCK expression
and not by HK2 knockdown (Supplementary Fig. 6). Lipid
accumulation upon GCK expression was also observed in Huh6
hepatoblastoma cells but not in epithelial kidney Vero cells,
indicating that this phenomenon occurs in metabolically relevant
cells (Supplementary Fig. 6).
Fig. 2 Hexokinase isoenzyme switch in Huh7 cells induces extended modifications of metabolic connections. a Western-blot analysis of HK1, HK2, HK3
and GCK expression in Huh7 and Huh7-GCK+/HK2−. b Hexokinase activity in homogenates of Huh7 and Huh7-GCK+/HK2− cells. Means ± SEM are
presented (n= 3). c Number of genes changing their expression pattern in Huh7 and Huh7-GCK+/HK2− cells (see Supplementary Data 2 for details).
d Heatmap showing clustering enrichment scores of the networks obtained when mapping differentially expressed genes to the human metabolic model
Recon2. Clustering enrichment scores from the highest in red to the lowest in blue were calculated for different gene expression thresholds (Log2 | FC | )
and percentages of retained currency metabolites. e Gene network corresponding to the maximal clustering enrichment score (Log2 | FC | > 3; removed
currency metabolites = 2%). The transcription of nodes in green was upregulated and those in red downregulated in Huh7-GCK+/HK2− compared to
Huh7 cells. Plain edges mark co-regulation between nodes and broken edges inverse regulation at the transcriptional level.
Table 1 Analysis of differentially expressed genes in Huh7 and Huh7-GCK+/HK2− using gene set enrichment analysis (| FC | > 2
with a p value <0.05).
Molecular and cellular functiona p value range Number of genes involved
Cellular movement 7.68 × 10−6–4.66 × 10−25 701
Lipid metabolism 2.00 × 10−6–3.12 × 10−14 414
Molecular transport 5.63 × 10−6–3.12 × 10−14 361
Small molecule biochemistry 5.63 × 10−6–3.12 × 10−14 462
Protein synthesis 1.87 × 10−6–3.42 × 10−14 199
aTop-five enriched molecular and cellular functions are presented.
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Differential lipid metabolism in Huh7 and Huh7-GCK+/HK2−.
The intracellular lipid content of the two cell lines was further
analyzed. In Huh7-GCK+/HK2−, an enrichment in phosphati-
dylcholine, cholesterol, triglycerides (TG) and free fatty acids was
observed compared to Huh7 (Fig. 4a). One major function of
hepatocytes is to secrete triglyceride-rich VLDL and this function
is altered in HCC cells that secrete smaller lipoproteins with the
density of LDL24,25. The secretion of lipids and lipoproteins by
both cell lines was analyzed after a 24h-culture in the absence of
fetal calf serum (FCS) to exclude any participation of exogenous
lipids in the production of lipoproteins. Huh7-GCK+/HK2−
secreted more free fatty acids than Huh7 while secretion of
cholesterol and TG remained unchanged (Fig. 4b). However,
under the same conditions, the secretion of apolipoprotein B
(ApoB) by Huh7-GCK+/HK2− was reduced compared to Huh7.
Since ApoB is a non-exchangeable protein with only one copy in
VLDL and LDL particles, an elevated TG/ApoB ratio indicates
that ApoB+-lipoproteins secreted by Huh7-GCK+/HK2− cells are
enriched in TG compared to those secreted by Huh7 (Fig. 4c).
This was confirmed by the ApoB distribution in density gradient
fractions. As expected, lipoproteins secreted by Huh7 sediment at
the density of LDL, while those secreted by Huh7-GCK+/HK2−
(Fig. 4d) match the density of VLDL found in human plasma or
secreted by primary human hepatocytes in culture26,27. This
indicates that GCK expression is essential for the VLDL assem-
bly/secretion pathway and could explain the loss of this crucial
metabolic pathway in hepatoma cells expressing HK2 instead of
GCK28.
Differential activity of the tricarboxylic acid cycle (TCA) in
Huh7 and Huh7-GCK+/HK2−. We observed that GCK expres-
sion increased the intracellular content in lipids, resulting in accu-
mulation of lipid droplets and secretion of VLDL. A rewiring of
cellular metabolism towards energy storage in Huh7-GCK+/HK2−
was thus suspected and confirmed by the accumulation of gly-
cogen, creatine and creatine-P (Fig. 5a, b), a feature of functional
hepatocytes. To further determine the consequences of replacing
HK2 by GCK, we quantified prominent intracellular metabolites
via gas chromatography coupled to triple-quadrupole (QQQ)
mass spectrometry (GC-MS). Figure 5c shows relative intracel-
lular quantities of metabolites that are significantly different
between Huh7 and Huh7-GCK+/HK2−. Among differentially
represented metabolites, higher levels of glucose, glycerol-3-
phosphate and lactic acid were detected in Huh7-GCK+/HK2−
cells. Several intermediates of the TCA cycle (succinic acid,
fumaric acid, alpha-ketoglutaric acid), and metabolites directly
connected to it (GABA, glutamic acid, glutamine, aspartic acid)
were also differentially present between the two cell lines. This
supports a modulation of central carbon metabolism at both the
level of glycolysis and TCA cycle. This led to investigate glucose
catabolism in further details. Glucose consumption and stable
Fig. 3 Huh7-GCK+/HK2− cells have a higher migration capacity and lipid droplets content. a, b Results of transwell-migration tests. a Representative
images and b count of migrating cells (n= 3). c Oil Red-O staining of lipid droplets (red) with nucleus counterstaining (blue). d Quantification of
intracellular lipids by FACS after BODIPY staining (n= 6). Means ± SEM are indicated and p values were determined by Student’s t-test.




p value Number of genes
involved
Concentration of lipid 3.12 × 10−14 256
Synthesis of lipid 2.37 × 10−10 233
Fatty acid metabolism 4.31 × 10−10 166
Quantity of steroid 4.48 × 10−09 138
Concentration of cholesterol 6.58 × 10−08 94




p value Number of genes
involved
Migration of cells 4.66 × 10−25 585
Cell movement 3.48 × 10−24 642
Cell movement of blood cells 1.52 × 10−18 276
Leukocyte migration 1.59 × 10−18 274
Invasion of cells 5.33 × 10−17 306
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isotope incorporation from [U-13C]-glucose into pyruvate were
both increased in Huh7-GCK+/HK2− compared to Huh7 cells
(Fig. 5d, e). This increased glycolytic flux together with a reduced
lactate secretion (Fig. 5d) is likely to account for the elevation
of lactate levels and suggest that the increased pyruvate produc-
tion essentially fuels mitochondrial TCA cycle in Huh7-GCK+/
HK2−cells.
Pyruvate entering the mitochondria downstream of glycolysis
can be either oxidized by pyruvate dehydrogenase (PDH),
producing acetyl-CoA, or converted into oxaloacetate (OAA) by
pyruvate carboxylase (PC). Acetyl-CoA and OAA are then
combined in the TCA cycle to form citrate. De novo lipogenesis
requires citrate egress from the TCA cycle to serve as a precursor
of cytosolic acetyl-CoA for further synthesis of fatty acids. In
Huh7-GCK+/HK2− cells, we observed both an increased activity
of PC (Fig. 5f) without changes in protein expression (Fig. 5g and
Supplementary Fig. 7a) and an increased phosphorylation of
pyruvate dehydrogenase (PDH), which is indicative of a reduced
activity of this enzyme (Fig. 5h and Supplementary Fig. 7b). This
is consistent with the increased expression of the PDH kinase
Fig. 4 Lipogenesis and very-low-density lipoproteins (VLDL) secretion are restored in Huh7-GCK+/HK2− cells. a Quantification of intracellular lipids in
total cell extracts of Huh7 and Huh7-GCK+/HK2− cells (n= 3). b Lipids and ApoB secretions in supernatants of cells cultured 24 h without FCS (n= 6 for
Cholesterol, n= 3 for FFA and n= 10 for TG and ApoB). c TG/ApoB molar ratio calculated from quantifications determined in b (n= 10). d Supernatants of
Huh7 and Huh7-GCK+/HK2− were analyzed by ultracentrifugation on iodixanol density gradients. ApoB was quantified in each fraction by ELISA (one
representative experiment). Presented data correspond to means ± SEM of indicated number of independent experiments and p values were determined by
Student’s t-test.
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PDK2 and the decreased expression of the PDH phosphatase
PDP2 in Huh7-GCK+/HK2− cells that regulate the PDH
phosphorylation state (Fig. 5i). A rebalanced usage of pyruvate
in Huh7-GCK+/HK2− cells maintains a functional TCA cycle
and supports lipogenesis. In Huh7-GCK+/HK2− cells, we also
observed an increased phosphorylation of ATP citrate lyase
(ACLY), the first enzyme of the fatty acid synthesis pathway,
indicating an enhanced activity of this enzyme (Fig. 5j and
Supplementary Fig. 7c). This reaction also regenerates OAA in
the cytosolic compartment. Interestingly, transcriptomic data
show that PCK1 which converts OAA to phosphoenolpyruvate
(PEP), is overexpressed in Huh7-GCK+/HK2− cells compared to
Huh7 (FC= 32).
A shift from pyruvate oxidation to carboxylation is observed in
cancer cells where succinate dehydrogenase (SDH) is inactivated
by mutation and OAA can only be generated through PC
activity29. SDH inhibition leads to succinate accumulation,
especially in activated immune cells30. Interestingly, higher levels
of succinate and a reduced activity of SDH were measured in
Huh7-GCK+/HK2− compared to Huh7 cells (Fig. 5k, l). Even
though SDH is also part of the complex II of the mitochondrial
respiratory chain, we observed that the overall oxygen
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consumption was increased in Huh7-GCK+/HK2− (Fig. 5m) with
increased basal and maximal respiration, ATP production and
spare respiration capacity (Supplementary Fig. 8). Functional
analysis of the respiratory chain showed that oxygen consump-
tion in Huh7 and Huh7-GCK+/HK2− cells was mainly dependent
on complex I activity (Fig. 5m, n). Thereby, the HK isoenzyme
switch rewired the TCA cycle promoting carboxylation of
pyruvate into OAA in the presence of a reduced SDH activity
and increased respiration through complex I.
Restored innate immune sensitivity in Huh7-GCK+/HK2−.
Lipid accumulation in hepatocytes is incriminated in hepatic
inflammation31 and TCA cycle rewiring is associated with innate
immunity activation32. These two events were observed when
replacing HK2 by GCK in Huh7 cells, questioning the immune
status of these cells and their sensitivity to antitumor immunity.
The functional analysis of gene ontology (GO) terms associated to
differentially expressed transcripts revealed an enrichment in
terms related to the regulation of innate immunity. The gene
signature associated with type-I interferon (IFN) signaling path-
way scored among the top enriched terms of upregulated tran-
scripts in Huh7-GCK+/HK2− cells (Supplementary Fig. 9).
Within the 91 gene members of this GO term, 20 transcripts of
Type I-IFN signaling were significantly up-regulated in Huh7-
GCK+/HK2− compared to Huh7 (Fig. 6a). This includes inter-
feron regulatory factors (IRF1, IRF3 and IRF9), IFN-stimulated
genes (ISGs) such as ISG15, MX1, OAS1, OAS3, RNaseL and
signaling intermediates such as IKBKE coding for IKKε (Fig. 6b).
The chaperon HSP90AB1, which is involved in the phosphor-
ylation and activation of STAT1, was also induced33. In contrast,
two genes were significantly down-regulated in Huh7-GCK+/
HK2− compared to Huh7, the RNaseL inhibitor ABCE1, and
TRIM6, an E3 ubiquitin-protein ligase regulating IKKε. Among
the members of the RIG-I-like receptor (RLR) family involved in
immune sensing and antitumor defense34, the expression of
IFIH1 (also known as MDA5) was slightly increased in Huh7-
GCK+/HK2−, while DDX58 (also known as RIG-I) itself
remained unchanged. Such identified gene sets suggest that
Huh7-GCK+/HK2− cells may be better equipped than Huh7 cells
to respond to innate immune signals. Thus, we compared the
innate immune response of the two cell lines when stimulated by
RIG-I or MDA5 ligands, known to sense different double-
stranded RNA (dsRNA) in viral immune recognition. In order to
quantify cellular activation by dsRNA, immuno-stimulatory
challenge assays were conducted with triphosphate-hairpin
RNA (3p-hpRNA) or polyinosinic-polycytidylic acid (poly(I:C)).
Interferon-sensitive response element (ISRE)-dependent tran-
scription was efficiently induced by these RLR ligands in Huh7-
GCK+/HK2− cells whereas Huh7 response was very limited even
at high doses of immuno-stimulatory ligands (Fig. 6c).
To investigate whether this differential sensitivity to RLR
ligands is linked to GCK expression or HK2 knockout, we used
Huh7 cells transduced for GCK expression so that they express
both HK2 and GCK (Huh7-GCK+/HK2+). In these cells, the
response to RIG-I ligation did not differ from that of Huh7 cells
suggesting that GCK expression alone is not sufficient to restore
immune sensitivity (Fig. 6d). When HK2 expression was
repressed in these cells with a shRNA (Huh7-GCK+/HK2−Sh)
(see Supplementary Fig. 10 showing 95% extinction of HK2
protein), ISRE response to RIG-I signaling was restored to a level
similar to that observed in Huh7-GCK+/HK2− cells (Fig. 6d).
This is pointing towards HK2 as a negative regulator of RLR
signaling in HCC cells and suggests that the GCK-to-HK2
isoenzyme switch during malignant transformation of hepato-
cytes is accompanied by a reduced sensitivity to innate immune
signals. The higher sensitivity to RLR ligands of Huh7-GCK+/
HK2− cells also resulted in increased secretion of inflammatory
interleukins (IL-6 and IL-8), antiviral cytokines (IFN-λ1, IFN-λ2/3,
IFN-β), and IP-10 (Fig. 6e), indicating that both NF-κB- and
IRF3-dependent signaling pathways were induced. IL-1β, TNFα,
IL-12p70, GM-CSF, IL-10 and IFNγ were not detected in the
supernatants of none of the cell lines, whether they were
stimulated or not.
As natural killer (NK) cell-mediated lysis of tumor cells is
crucial for the anti-cancer immune defense, we compared the
susceptibility of the two cell lines to NK cells cytotoxicity.
Figure 6f shows that Huh7 cells are resistant to NK cell-mediated
lysis in contrast to Huh7-GCK+/HK2−. Thus, replacing HK2 by
GCK restored Huh7 sensitivity to NK cell-mediated lysis. Similar
results were obtained when NK cells were pre-activated with IL-2
(Supplementary Fig. 11). Altogether, these results demonstrate
that HCC cells expressing HK2 instead of GCK exhibit an
impaired response to immune signals and also a strong resistance
to NK cells. These two observations are in line with clinical data
showing that elevated GCK expression is associated with
prolonged survival, while elevated HK2 expression coinciding
with GCK reduction correlates with shorter overall survival
(Fig. 1).
Discussion
Metabolic network rewiring is a hallmark of cancer although for
most tumors, mechanisms at the origin of this metabolic repro-
gramming have not been elucidated. While GCK, but not HK2, is
expressed in normal hepatocytes, the expression of HK2 occurs
during cirrhosis and increases as the disease progresses to carci-
noma. Several signaling pathways such as hypoxia inducible
Fig. 5 TCA rewiring after hexokinase isoenzyme switch in Huh7 cells. a Glycogen quantification. b Creatinine and creatinine-P quantification. c This
bubble chart compares intracellular metabolomes of Huh7 and Huh7-GCK+/HK2− cells. Metabolite pool sizes larger in Huh7 are indicated in blue, whereas
the one larger in Huh7-GCK+/HK2− are shown in red. The size of bubbles inversely scales with p values between 5.10−2 and 1.10−17 of differential
metabolomics responses. d Metabolic fluxes for overall glucose consumption and lactate secretion by Huh7 and Huh7-GCK+/HK2− cells. Indicated values
correspond to differences in glucose or lactate concentrations in extracellular culture medium before and after 24 h of culture. e Mass isotopomer
distribution vector of pyruvate in cells cultured with [U-13C]-glucose. Presented data correspond to n= 24 (c, d) or n= 16 (e) acquired spectra from N= 6
and N= 4 independent specimens, respectively. f Pyruvate carboxylase (PC) activity determined in cell homogenates. g Western-blot analysis of PC
expression in Huh7 and Huh7-GCK+/HK2− cells. h Western-blot analysis of pyruvate dehydrogenase (PDH) E1-alpha subunit phosphorylation at Ser293.
i RNA-seq quantification of pyruvate dehydrogenase kinase 2 (PDK2) and pyruvate dehydrogenase phosphatase 2 (PDP2) (BH adjusted p value<0.05 from
transcriptomic data). j Western-blot analysis of ATP-citrate Lyase (ACLY) phosphorylation at Ser455. k Succinate quantification in cell homogenates.
l Succinate dehydrogenase (SDH) activity determined in cell homogenates. m Oxygen consumption rate (OCR) in Huh7 and Huh7-GCK+/HK2− cells was
determined with a Seahorse analyzer before and after the addition of oligomycin (Complex V inhibitor), FCCP (uncoupling agent), rotenone (Complex
I inhibitor) and antimycin A (Complex III inhibitor) (n= 5). n Non-mitochondrial, complex I-dependent and complex III-dependent maximal OCR were
calculated from m. Except otherwise indicated, data correspond to means ± SEM of 3 independent experiments and p values were determined by Student’s
t-test.
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Fig. 6 Innate immune response is enhanced in Huh7-GCK+/HK2− cells. a Sector chart from the transcriptomic study showing genes included in the GO-
term “Type I-IFN signaling pathway”. b List of genes significantly up-regulated in red or down-regulated in purple (| FC | > 2, BH adjusted p value<0.05) in
Huh7-GCK+/HK2− compared to Huh7 cells (n= 3). c–e Cells were stimulated or not for 48 h with 3p-hpRNA (RIG-I ligand) or poly(I:C) (IFIH1/MDA5
ligand). ISRE-luciferase expression was monitored and normalized to Renilla luciferase (c, d) (n= 3 for 3p-hpRNA and n= 4 for poly(I:C) treatments). Cell
supernatants were assayed for cytokine concentration by multiplex assays (n= 3 to 7) (e). f NK cell mediated lysis of Huh7 or Huh7-GCK+/HK2− cells.
Hepatoma cells were seeded 24 h before NK cells addition for 4 h at effector to target (E:T) ratio of 0, 3 or 30. After harvesting, cell lysis was determined
by the percentage of PI+ cells on gated hepatocytes (n= 3). Means ± SEM of indicated n independent experiments are presented and p values were
obtained from 2-way ANOVA analyses comparing matched cell means with Sidak’s correction for multiple comparison, with α= 0.05.
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factors (HIF), peroxisome proliferator-activated receptors
(PPAR) and phosphatidylinositol-4,5-bisphosphate 3-kinase
(PI3K) might contribute to HK2 induction in fatty liver disease
and its evolution towards cirrhosis and carcinogenesis35–37.
Consequently, HK2 induction has been proposed as a risk marker
of HCC development16. Analyzing TCGA data from human HCC
tumors, we observed that not only high levels of HK2 but also low
levels of GCK are of poor prognosis. In contrast, neither HK1 nor
HK3 expression levels were correlated with survival of HCC
patients. GCK expression is very low or not detected in biopsies
from a majority of patients (65.8% of patients show RSEM values
<10), whereas HK2 is widely expressed16 (only 5.8% of patients
show RSEM values <10). This probably explains that HK2
expression is a better prognostic marker than GCK for HCC.
However, when GCK and HK2 expression were combined into a
single ratio, this prognostic marker outperformed HK2 or GCK
expression alone. This suggests that both HK2 induction and
GCK loss play a role in HCC progression. As HK2 and GCK
expression tend to be mutually exclusive, both HK2 induction
and GCK downregulation might have consequences on the
metabolic reprogramming during malignant transformation of
hepatocytes. To compare the functional consequences of the HK
isoenzyme switch in HCC, we therefore expressed GCK in the
reference HCC cell line Huh7 and knocked-down HK2 expres-
sion. Our comparative transcriptomic, metabolic and functional
studies demonstrate that the replacement of HK2 by GCK not
only restored some essential metabolic functions of normal
hepatocytes such as lipogenesis, VLDL secretion and glycogen
storage but also reactivated innate immune responses and sen-
sitivity to NK-mediated cell lysis.
HCC cell lines predominantly secrete LDL-like particles, unlike
normal hepatocytes, which secrete VLDL. Lipid loading of Huh7
cells with oleic acid can boost the secretion of ApoB+ particles
but does not induce a shift from LDL to VLDL density, indicating
that intracellular fatty acid accumulation of exogenous origin
cannot rescue VLDL production28. Here we show that replacing
HK2 by GCK in Huh7 cells restored de novo fatty acid synthesis,
allowing VLDL assembly/secretion in the absence of exogenous
lipids. To our knowledge Huh7-GCK+/HK2− is the first human
cell model with a functional VLDL secretion pathway. Such a tool
will strongly benefit the field of cardiovascular diseases and
hepatic steatosis.
De novo fatty acid synthesis from carbohydrates requires an
adequate supply in metabolic substrates, especially citrate that is
produced by the TCA cycle from incoming pyruvate. The gly-
colytic entry point into the TCA cycle is controlled by PDH and
PC that convert pyruvate into acetyl-CoA or OAA, respectively.
Our data revealed that in addition to the increased production of
pyruvate from glucose, PC activity is increased whereas PDH is
inhibited. This suggests that pyruvate metabolism is rebalanced in
favor of OAA in Huh7-GCK+/HK2− cells, as described in healthy
liver. Such a mechanism of anaplerosis is known to replenish
TCA cycle intermediates and compensate citrate export out of the
mitochondria for lipogenesis fueling. Increased PC activity is
observed in both normal and pathological situations, mainly as a
result of an increased transcription of the PC gene. In our model,
mRNA and protein levels were not affected, indicating that PC
activity can be regulated by alternative mechanisms depending on
HK isoenzyme expression. This may relate to lower levels of
oxalate, a known inhibitor of PC activity, in Huh7-GCK+/HK2−
cells (Fig. 5c and Fig. 7 discussed below).
A rebalanced pyruvate usage in favor of OAA is also described
for instance in SDH-deficient neuroendocrine tumor cells, where
succinate accumulates and PC activity is increased to maintain
OAA production, replenish the oxidative TCA cycle and support
aspartate synthesis29. Interestingly, in comparison to Huh7 cells,
succinate and aspartate levels are elevated in Huh7-GCK+/HK2−
where SDH activity is reduced, suggesting a direct link between
PC and SDH activity in hepatocytes. Several mechanisms inhi-
biting SDH have been described38. Modification of the expression
of SDH subunits is unlikely as no variation was observed at the
transcriptomic level. Itaconate is a weak inhibitor of SDH pro-
duced from aconitate by Immune-responsive gene 1 protein
(IRG1; encoded by ACOD1), but this metabolite was not detected
and IRG1 mRNA was absent from the transcriptome of both cell
lines. Whether fumarate or other metabolites are responsible for
the reduced SDH activity in GCK-expressing cells remains to be
investigated. Finally, SDH-deficient cells and LPS-stimulated
macrophages have been shown to elicit a hypoxic-like phenotype
through accumulation of large amounts of succinate and stabili-
zation of HIF-1α39,40. Despite an elevated succinate steady-state
level in Huh7-GCK+/HK2− compared to Huh7 cells, we observed
no difference in HIF-1α stabilization neither at basal level nor
upon induction (Supplementary Fig. 12). This suggested that the
reduction of SDH activity in Huh7-GCK+/HK2− cells was not
strong enough to induce such a pseudo-hypoxic phenotype.
Our gene-centric metabolic analysis of transcriptomic data
revealed a wide spreading of metabolic modifications resulting
from HK isoenzyme switch. Illustrating these modifications,
Fig. 7 is an attempt to integrate the observed changes in central
carbon metabolism and closely connected metabolic pathways. In
particular, decreased level of alanine and increased aspartate
concentration in Huh7-GCK+/HK2− cells could be an indirect
effect of PC activation that uses pyruvate for the synthesis of
OAA. As a consequence, hepatic transaminases may balance
intracellular pools of OAA, aspartate, alanine and pyruvate.
Glutamate and GABA levels were also modified, thus supporting
anaplerosis of the TCA cycle through glutamine consumption
and the GABA shunt pathway, respectively. We also observed
lower levels of oxalate, an end-product of glyoxylate degradation.
In Huh7-GCK+/HK2− cells, increased levels of alanine-glyoxylate
and serine-pyruvate aminotransferase (AGXT) could account for
this phenotype as it converts alanine and glyoxylate into pyruvate
and glycine, which is also increased. Interestingly, high level of
AGXT is a good prognostic marker for HCC41. Consistently, it
was found that oxalate inhibits liver PC, resulting in reduced
gluconeogenesis and lipogenesis42,43. Thus, a higher PC
activity could be explained by lower levels of oxalate in Huh7-
GCK+/HK2− cells. We also observed that isoleucine and valine
levels increased while branched chain amino acid transaminase 1
(BCAT1) predominant transcripts decreased. This suggests a
reduced catabolism of branched chain amino acids in Huh7-
GCK+/HK2− cells. Again, low levels of BCAT1 is a good prog-
nostic marker for HCC and oral supplementation with branched
chain amino acids has been shown to reduce the risk of liver
cancer in cirrhotic patients44,45. If some metabolic modifications
seem to advocate for the restoration of a normal hepatocyte
phenotype following the replacement of HK2 by GCK, it cannot
be a general statement. Indeed, the urea cycle was also impacted
in Huh7-GCK+/HK2− cells with lower levels of CPS1 and OTC,
which are also observed in aggressive HCC tumors46. Altogether,
our results demonstrate the broad impact of replacing HK2 by
GCK in HCC cells, and the key role played by the HK isoenzyme
switch in HCC tumor metabolism.
We discovered that HK isoenzyme expression not only con-
trols hepatic metabolic functions but also interferes with intrinsic
innate immunity of hepatocytes and antitumor immune surveil-
lance. Several reports have recently established functional links
between glucose metabolism and signaling pathways downstream
of innate immunity sensors of the RLR family, RIG-I and
MDA547–49, which are usually associated with antiviral responses.
However, RIG-I expression is downregulated in hepatic cancer
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tissues and low RIG-I expression is correlated with poor survival
of patients, whereas RIG-I expression in HCC cell lines enhanced
IFN response and cancer cell apoptosis34. This suggests an
unexpected role of this receptor family in the antitumor response.
Here we show that Huh7 cells expressing GCK instead of HK2
exhibit a higher sensitivity to RIG-I and MDA5 ligands, and
produce higher levels of type I/III IFNs and inflammatory cyto-
kines. This immune phenotype occurs in a context of reduced
SDH activity and increased intracellular content in succinate
(Fig. 5k, l). A pro-inflammatory function of immune cells such as
macrophages was previously linked to TCA rewiring, with
reduced SDH activity resulting in succinate accumulation39,50,51.
Succinate can also be secreted from LPS-activated macrophages
and activate its cognate receptor, succinate receptor 1 (SUCNR1,
previously known as GPR91) in an autocrine and paracrine
manner to further enhance production of IL-1β52. Interestingly,
glucose metabolism promotes RIG-I and MDA5 signaling
through the O-GlcNAcylation of the mitochondrial adaptor
MAVS47. Thus, an intriguing hypothesis is that GCK expression
could facilitate MAVS signaling by increasing UDP-GlcNAc
through upregulation of the hexosamine biosynthetic pathway.
HK2 binding at the surface of mitochondria may also compete
with pyruvate carboxylase, metabolites or mitochondria factors
known to control MAVS signaling47–49. Here we show that HK2
knockdown promotes RIG-I-induced ISRE-dependent transcrip-
tion (Fig. 6d). This is consistent with the results obtained by
Zhang et al.48, indicating that HK2 interaction with MAVS
restrains RIG-I-induced IFN-β secretion. Further investigations
are now required to decipher the molecular links between
metabolism and immune responses.
Beyond the inhibition of RLR signaling, other mechanisms
might contribute to tumor escape from immune surveillance in
HCC patients. In advanced-stage HCC patients, NK cells often
exhibit reduced infiltration and impaired functional activities53.
We thus compared the sensitivity of Huh7-GCK+/HK2− cells to
Huh7, and found that sensitivity to NK cell lysis is restored when
HK2 is replaced by GCK. When analyzing cell surface expression
of the NK cells inhibitors, HLA class I and MICA/B, no sig-
nificant changes were observed between cell lines (Supplementary
Fig. 13). In contrast, an increased transcription and surface
expression of ICAM1 (FC= 2.6; Supplementary Fig. 13) was
observed in Huh7-GCK+/HK2−. Since ICAM1 binding to active
LFA-1 at the surface of NK cells is essential for granule polar-
ization and efficient killing of the target cells54, its enhanced
exposition at the surface of Huh7-GCK+/HK2− cells may con-
tribute to their higher sensitivity to NK cell-mediated killing.
These results suggest that HK2 expression at the expense of GCK
in HCC tumors decreases immune responsiveness and sensitivity
to NK cytotoxicity, thus favoring immune escape.
Taken together, our data demonstrate that beyond glycolysis,
the hexokinase isoenzyme switch in an HCC model rewires
central carbon metabolism, promotes lipogenesis, enhances
innate immune functions, and restores sensitivity to natural
killer cells.
Methods
Materials. Unless otherwise specified, chemicals were from Merck Sigma-Aldrich.
The RIG-I specific ligand 3p-hpRNA and the MDA5/TLR3 ligand poly(I:C) HMW
(High Molecular Weight) were from Invivogen.
Cell cultures. Cell cultures were tested negative for mycoplasma contamination by
PCR (mycoplasma check, eurofins). Huh7 cells were authenticated by Eurofins
Medigenomix Forensik GmbH using PCR-single-locus-technology. 21 independent
PCR-systems Amelogenin, D3S1358, D1S1656, D6S1043, D13S317, Penta E,
D16S539, D18S51, D2S1338, CSF1PO, Penta D, TH01, vWA, D21S11, D7S820,
D5S818, TPOX, D8S1179, D12S391, D19S433 and FGA (Promega, PowerPlex 21
PCR Kit) were investigated to determine their genetic characteristics. Huh7 cells
and derivatives were grown as previously described55 in DMEM, 10% fetal calf
serum (FCS), penicillin/streptomycin, 1 mM pyruvate, 2 mM L-glutamine. Culture
medium and additives were from Gibco except FCS (Dominique Dutcher).
Cell lines. 15×104 Huh7 cells were transduced for GCK expression at different
multiplicities of infection (lentiviral transduction using the pLEX-GCK construct).
The Huh7-GCK+/HK2+ cells were then cultured for 7 days with puromycin
(1 μg/mL) before amplification. HK2 knock-out was achieved using the CRISPR/
Cas9 system as previously described56 to obtain Huh7-GCK+/HK2− cells. Briefly, a
single guide RNA (sgRNA) pair was designed for double nicking using the CRISPR
Design Tool (http://tools.genome-engineering.org). The guide sequence oligos
(sgRNA1(HK2): 5’-CACCGTGACCACATTGCCGAATGCC-3’ and
sgRNA2(HK2): 5’-CACCGTTACCTCGTCTAGTTTAGTC-3’) were cloned into a
plasmid containing sequences for Cas9 expression and the sgRNA scaffold
(pSpCas9(BB)-2A-GFP, Addgene plasmid #48138). 48 h post-transfection, cells
were sorted by FACS based on the transient expression of GFP and cloned by
limiting dilution. Effective deletion of HK2 was assessed by qPCR.
For HK2 knock-down, Huh7-GCK+/HK2+ cells were transduced with lentiviral
vectors expressing HK2-targeting shRNAs, and antibiotic selection was applied
(hygromycin; 100 µg/ml). The HK2-targeting sequence 5’-
Fig. 7 Simplified scheme of central carbon metabolism and connected pathways showing differences between Huh7-GCK+/HK2− vs Huh7. Highlighted
metabolites, enzymatic activities, and metabolism-associated genes were selected from transcriptomic (Fig. 2e), metabolomic (Fig. 5c) and enzymatic
analyses (Fig. 5f–l).
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CCGGCCAGAAGACATTAGAGCATCTCTCGAGAGATGCTC-
TAATGTCTTCTGGTTTTTT-3’ was cloned in the pLKO.1 hygro vector (a gift
from Bob Weinberg; Addgene plasmid #24150). HK2 expression in Huh7-GCK+/
HK2+ and Huh7-GCK+/HK2−Sh was analyzed on cell lysates by western blotting
(Supplementary Fig. 10).
Enzymatic activity assays. Cells were trypsinized, washed twice, and cell pellets
were stored at −80 °C. Protein extractions and assays were performed in specific
buffers for hexokinase and pyruvate carboxylase assays as described below.
Hexokinase activity assay. The method used for monitoring HK activity in cells
lysates was adapted from Kuang et al.57–59. Cellular pellets stored at −80 °C were
thawed and immediately homogenized (2×106 cells/100 µl) in precooled reaction
buffer. (0.05 M Tris–HCl, 0.25M sucrose, 0.005 M EDTA, 0.005 M 2-mercap-
toethanol, pH = 7.4). After 20 min incubation on ice, homogenates were pulse-
sonicated 15 s at half power (EpiShear Probe Sonicator). Homogenates were then
centrifuged at 500 g for 20 min at 4 °C. Supernatants were immediately used for
determination of HK activity, which was measured spectrophotometrically through
NADP+ reduction in the glucose 6-phosphate dehydrogenase–coupled reaction.
HK activity was assayed in medium containing 50 mM triethanolamine (pH= 7.6),
10 mM MgCl2, 1.4 mM NADP+, with variable concentration of glucose and 1 U
glucose 6-phosphate dehydrogenase (S. cerevisiae), equilibrated to 37 °C. The
reaction was started by addition of ATP (final concentration 1.9 mM), and
absorbance was continuously recorded for 30 min at 340 nm (TECAN
Infinite M200).
Pyruvate carboxylase activity assay. The method used for quantification of PC
activity was adapted from Payne et al.60. Briefly, cells were centrifuged, washed
twice with ice-cold PBS before homogenization in Tris-HCL 100 mM, pH = 8.0
using a Dounce homogenizer. Homogenates were pulse-sonicated 15 s at half
power (EpiShear Probe Sonicator) before centrifugation at 500 g for 5 min.
Supernatants were immediately used for the assay. PC activity was assayed in
medium containing 100 mM Tris-HCl, 50 mM NaHCO3, 5 mM MgCl2, 0.1 mM
Acetyl-CoA, 0.25 mM 6,6′-Dinitro-3,3′-dithiodibenzoic acid (DTNB), 5 mM ATP,
5 mM pyruvate, citrate synthase and cofactors. Reduction of DTNB by the gen-
erated free CoA was measured continuously by Abs at 412 nm and recorded for
30 min (TECAN Infinite M200). The same assay was performed in absence of
pyruvate to subtract background signal.
Metabolomics profiling. Cells were seeded at 13×105 cells per 75 cm2 dishes. After
24 h, supernatant was removed and replaced by fresh culture medium. For quan-
tification of metabolic flux from glucose, culture medium was supplemented with
both [U-13C]-glucose (Sigma-Aldrich; 389374-2 G) and unlabeled glucose at a
50:50 ratio (final concentration of 25 mM glucose). After 24 h, cells were harvested,
washed twice with ice-cold PBS and cell pellets were frozen at -80 °C until meta-
bolites extraction. Cell pellets were transferred into a pre-chilled microcentrifuge
tube with 1 mL cold extraction buffer consisting of 50% methanol (A452, Fisher
Scientific) in ultrapure water. Samples were then frozen in liquid nitrogen, thawed,
and placed in a shaking dry bath (Thermo Fisher Scientific, Waltham, MA) set to
1100 rpm for 15 min at 4 °C. After centrifugation for 15 min at 12500 g and 4 °C
(Sorvall, Thermo Fisher Scientific) using a fixed-angle F21-48×1.5 rotor, super-
natants were collected and dried by vacuum centrifugation overnight. Dried
metabolites were derivatized by addition of 20 μL of 2.0% methoxyamine-
hydrochloride in pyridine (MOX, TS-45950, Thermo Fisher Scientific) followed by
incubation during 90 min in shaking dry bath at 30 °C and 1100 rpm. Ninety μL of
N-methyl-N-trimethylsilyltrifluoroacetamide (MSTFA, 701270.201, Macherey-
Nagel) was added, and samples were incubated and shaken at 37 °C for 30 min
before centrifugation for 5 min at 14,000 rpm and 4 °C. Metabolites contained in
the supernatant were then separated by gas chromatography (GC, TRACE 1310,
Thermo Fisher Scientific) coupled to a triple-quadrupole mass spectrometry system
for analysis (QQQ GCMS, TSQ8000EI, TSQ8140403, Thermo Fisher Scientific),
equipped with a 0.25 mm inner diameter, 0.25 μm film thickness, 30 m length 5%
diphenyl / 95% dimethyl polysiloxane capillary column (OPTIMA 5 MS Accent,
725820.30, Macherey-Nagel) and run under electron ionization at 70 eV. Using
established separation methods61–63, the GC was programed with an injection
temperature of 250.0 °C and splitless injection volume of 1.0 μL. The GC oven
temperature program started at 50 °C (323.15 K) for 1 min, rising at 10 K/min to
300.0 °C (573.15 K) with a final hold at this temperature for 6 min. The GC flow
rate with helium carrier gas (HE, HE 5.0UHP, Praxair) was 1.2 mL/min. The
transfer line temperature was set at 290.0 °C and ion source temperature at
295.0 °C. A range of 50–600 m/z was scanned with a scan time of 0.25 s.
Metabolomics data processing. Metabolites were identified using TraceFinder
(v3.3, Thermo Fisher Scientific) based on libraries of metabolite retention times
and fragmentation patterns (Metaflux, Merced, CA). Identified metabolites were
quantified using the selected ion count peak area for specific mass ions, and
standard curves generated from reference standards run in parallel. Peak intensities
were median normalized. The mean and standard deviation for each quantified
metabolite was calculated for each cell line and treatment condition. A univariate
t-test was used to compare treatment conditions for each metabolite and cell line.
Transcriptome profiling of Huh7 and Huh7-GCK+/HK2− cell lines. Tran-
scriptome profiling was performed by next generation sequencing (ProfileXpert,
Lyon, France). Briefly, Total RNA was extracted and purified from cell pellets using
Direct-zol RNA purification kit (Zymo Research). 700 ng of total RNA were
amplified (NextFlex Rapid Directional mRNA-Seq, PerkinElmer) to generate
mRNA-seq libraries. Then, gene expression was analyzed by Next-Generation
Sequencing (NGS) using Illumina NextSeq500. Reads were mapped on the refer-
ence genome Homo sapiens GRCh37/hg19. Raw data were processed using the
DESeq2 pipeline64 to identify differentially expressed genes. See Supporting
Information and Gene Expression Omnibus database with the accession number
GSE144214 for entire raw data.
Pathway analysis. The list of transcripts differentially expressed in Huh7 and
Huh7-GCK+/HK2− cell lines was analyzed by gene set enrichment analysis (IPA,
Build version: 486617M, Qiagen) weighted by their corresponding fold change and
p value. The fold change cut-off of mean expression for each transcript was set at 2
with an adjusted p value<0.05. The list of genes associated with “Type I-IFN
signaling pathway” was defined in the AmiGO 2 database. Expression data of these
genes were retrieved from the transcriptomes of Huh7-GCK+/HK2− and Huh7,
and correspond for each gene to the most differentially expressed transcript.
Cell migration assay. 2×104 cells were plated in the upper chamber of transwells
(Sarstedt, PET 8.0-μm, TL - 833932800) with DMEM without FCS to allow
migration for 24 h at 37 °C. DMEM with 10% FCS was distributed in each well,
below the chamber. Chambers were gently picked up before a brief PBS rinse and
0.05% crystal violet coloration. The migrated cells were analyzed a Leica M50
microscope using a magnification factor of 20x. The number of cells that have
migrated through the membrane and attached on the underside of the membrane
were counted using the software Image J.
Intracellular lipid staining. For fluorescence microscopy staining of intracellular
lipids, cells were seeded and cultured during 48 h before staining with Oil-Red-O.
Cells were fixed 15 min at RT with a 4% formaldehyde solution, washed twice with
water before a 5 min incubation with isopropanol 60%. Isopropanol was then
removed and Oil-Red-O solution (Millipore Sigma-Aldrich) added on cells for
15 min at RT. Cells were then extensively washed with water to remove the
exceeding dye before nucleus counterstaining with NucBlue Fixed Cell Stain
ReadyProbes reagent (ThermoFisher Scientific) and observation with a Nikon
Eclipse Ts2R microscope (x60). For the quantification of intracellular lipid droplets
by flow-cytometry, cells were stained with the BODIPY® 493/503 dye (Tocris Bio-
Techne) after 48 h of culture. The cells were washed with PBS before being incu-
bated for 5 min with a 5 μM BODIPY solution in PBS at 37 °C. Cells were then
washed with PBS before trypsination and FACS analysis. A 7-AAD (BioLegend)
staining of dead cells, prior to FACS analysis, allowed gating on living cells.
Protein, ApoB, and lipid quantification. Protein concentration was determined
using the DC Protein Assay (Bio-Rad). ApoB concentration in medium and gra-
dients fractions was determined by ELISA as previously described65. Total con-
centrations of cholesterol, phospholipids, and triglycerides (TG) were determined
using specific assays from Millipore Sigma-Aldrich (ref. MAK043, MAK122 and
MAK266 respectively). Free Fatty Acids were quantified using a specific assay kit
from Abcam (ref. ab65341).
Iodixanol density gradients. Iodixanol gradients were prepared as previously
described66. One ml of culture supernatant was applied to the top of 6 to 56%
iodixanol gradients and centrifuged for 10 h at 41,000 rpm and 4 °C in a SW41
rotor. The gradient was harvested by tube puncture from the bottom and collected
into 22 fractions (0.5 ml each). The density of each fraction was determined by
weighing.
Metabolic network coherence computational analysis. In order to measure the
consistency of differentially expressed genes with a metabolic network, we
employed the metabolic network coherence measure introduced by Sonnenschein
et al.67. This approach was previously applied to various disease-related tran-
scriptome profiles68,69 and for extracting information on the genetic control of
metabolic organization70. Recently, detailed theoretical analysis of the extended
version of the method has been performed by Nyczka and Hütt71. Here, we first
extracted a gene-centric metabolic network from a given genome-scale metabolic
model. This was achieved via the stoichiometric matrix and the gene-reaction
associations contained in the metabolic model. We constructed the two projections
of the bipartite graph represented by the stoichiometric matrix, yielding a
metabolite-centric and a reaction-centric graph. The metabolite-centric graph
allowed us to identify high-degree nodes (‘currency metabolites’ like H2O, ATP,
etc.), which are not informative about the network-like organization of the meta-
bolic systems and need to be eliminated before interpreting the network
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architecture (see references68,72 for details). The degree of a node is the number of
neighbors the node has in the network. The percentage of remaining metabolites is
one of the parameters of our analysis. Typical values are 90 to 98 percent (i.e. a
removal of the highest 2 to 10% of metabolites with the highest degree as currency
metabolites). After recomputing the reaction-centric graph based on the reduced
number of metabolites (Supplementary Fig. 3), we can now evaluate the gene-
reaction associations to arrive at a gene-centric metabolic network (Supplementary
Fig. 3). Given a set S of differentially expressed genes and the gene-centric meta-
bolic network G, we can now analyze the subgraph of G spanned by all genes in S.
The average clustering coefficient C in these subgraphs serves as a measure of the
connectivity of this subgraph. The metabolic network coherence MC is the z-score
of C computed with respect to a null model of randomly drawn gene sets with the
same size as S (Supplementary Fig. 4). In this way, MC has an intuitive inter-
pretation: The value of MC indicates, how many standard deviations away from
randomness the clustering of the subgraph spanned by the observed gene set S
actually is (Supplementary Fig. 4 and reference73). The genome-scale metabolic
models employed here are the generic human metabolic model Recon 222. In
general, different network measures can be used for evaluation of MC. In the scope
of this study, we have tested several of them, but opted for average clustering
coefficient C, as it yielded strongest statistical signal.
Western-blot analysis. Cell lysates from 106 cells were prepared in lysis buffer
(1% Triton X-100, 5 mM EDTA in PBS with 1% protease inhibitor cocktail (P8340;
Millipore Sigma-Aldrich) and 2 mM orthovanadate). After elimination of insoluble
material, proteins were quantified, separated by SDS-PAGE and analyzed by
western-blot on PVDF membrane. After saturation of the PVDF membrane in
PBS-0.1% Tween 20 supplemented with 5% (w/v) non-fat milk powder, blots were
incubated 1 h at room temperature with primary antibody in PBS-0.1% Tween 20
(1:2,000 dilution for all antibodies unless specified otherwise). Incubation with
secondary antibody was performed after washing for 1 h at room temperature.
HRP-labeled anti-goat (Santa Cruz Biotechnology), anti-rabbit (A0545, Millipore
Sigma-Aldrich) or anti-mouse (Jackson ImmunoResearch Laboratories) antibodies
were diluted 20,000 folds and detected by enhanced chemiluminescence reagents
according to the manufacturer’s instructions (SuperSignal Chemiluminescent
Substrate, Thermo Fisher Scientific). Primary antibodies used for immunoblotting
included mouse monoclonal antibody against human GCK (clone G-6, Santa Cruz
Biotechnology), rabbit monoclonal antibody against human HK2 (Clone C64G5,
Cell Signaling Technology), rabbit monoclonal antibody against human HK1
(C35C4, Cell Signaling), rabbit polyclonal antibody against human HK3
(HPA056743, Millipore Sigma-Aldrich), goat polyclonal antibody against human
ACLY (SAB2500845, Millipore Sigma-Aldrich), rabbit polyclonal antibody against
human pACLY (phospho S455, Cell Signaling Technology), rabbit monoclonal
antibody against human PDH α1 subunit (C54G1, Cell Signaling Technology),
rabbit monoclonal antibody against human pPDH E1-alpha subunit (phospho
S293, Abcam), goat polyclonal antibody against human PC (SAB2500845, Milli-
pore Sigma-Aldrich), rabbit monoclonal antibody against human GAPDH
(D16H11, Cell Signaling Technology) and rabbit polyclonal antibody against
human HIF-1α (NB100-134, Novus Biologicals; 1:500 dilution).
Respiration assay. Twenty-four hours prior measuring respiration in the Extra-
cellular Flux Analyzer (Seahorse Bioscience), cells were seeded in XF 24-wells cell
culture microplates (Seahorse Bioscience) at 5×104 cells/well in 100 µL of DMEM
medium supplemented with 10% FCS, 1 mM pyruvate, 2 mM L-glutamine, peni-
cillin/streptomycin, and then incubated at 37 °C/5% CO2 during 5 h for cell
attachment. Medium volume was adjusted to 250 µL and cells incubated overnight.
The assay was initiated by removing the growth medium from each well and
replacing it with 500 µL of Seahorse assay medium (XF DMEM pH = 7.4+ 10 mM
Glucose, 2 mM Glutamine and 1 mM sodium pyruvate) prewarmed at 37 °C. Cells
were incubated at 37 °C for 1 h to allow media temperature and pH to reach
equilibrium before the first measurement. The oxygen consumption rate (OCR)
was measured using the following Seahorse running program: injection Port A –
1.5 µM Oligomycin; Injection Port B – 0.5 µM FCCP and injection Port C – 0.5 µM
Rotenone; injection port D – 0.5 µM Antimycin A. The number of cells was
determined at the end of the run after Hoechst staining and cell counting using
Cytation 1 imaging reader (Biotek).
RLR stimulation. Cells were seeded in 96-well or 24-well plates. After 24 h, cells
were co-transfected with indicated doses of the RIG-I ligand 3p-hpRNA or the
MDA5/TLR3 ligand poly(I:C) HMW together with the pISRE-luc (1.25 µg/ml;
Stratagene) and pRL-SV40 (0.125 µg/ml; Promega) reporter plasmids using the
JetPEI-Hepatocyte reagent (Polyplus Transfection). Manufacturer’s instructions
were followed. After 48 h, supernatants were collected for cytokine quantification.
Firefly and Renilla luciferase expressions within cells were determined using the
Dual-Glo luciferase Assay system (Promega) and an Infinite M200 microplate
reader (TECAN).
Cytokine assays. Clarified culture supernatants were collected and stored at
−20 °C. IL-8 was quantified using the Cytometric Bead Array for human IL-8 (BD
Biosciences). Other cytokines were assayed using the LEGENDplex multiplex assay
(Human Anti-Virus Response Panel, BioLegend). Fluorescence was analyzed using
a FACS Canto II (BD Biosciences).
Human NK cell purification. NK cells were isolated from human buffy coats of
healthy donors obtained from the Etablissement Français du Sang. Informed
consent was obtained from donors and experimental procedures were approved by
the local institutional review committee. PBMCs were isolated by standard density
gradient centrifugation on Ficoll-Hypaque (Eurobio). Mononuclear cells were
separated from peripheral blood lymphocytes (PBLs) by centrifugation on a 50%
Percoll solution (GE Healthcare). NK cells were purified from PBLs by immuno-
magnetic depletion using pan-mouse IgG Dynabeads (Thermo Fisher Scientific)
with a cocktail of depleting monoclonal antibodies: anti-CD19 (4G7 hybridoma),
anti-CD3 (OKT3 hybridoma, ATCC, Manassas, VA, USA), anti-CD4, anti-CD14
and anti-glycophorin A (all from Beckman Coulter). NK purity was >70% as
assessed by CD56 labeling.
NK cell cytotoxicity test. Huh7 or Huh7-GCK+/HK2− were seeded at 1×105 cells
per well in a 24-well plate in RPMI-1640 (Gibco) with 10% FCS and 40 µg/ml
gentamycin. After 24 h, 3×105 or 3×106 NK cells were added to the culture wells.
The cytotoxicity assay was performed for 4 h at 37 °C, under 5% CO2. Target
hepatoma cells were harvested after trypsination, labeled with propidium iodide
(PI) and analyzed by FACS. Cell death was monitored after morphological gating
on hepatocytes.
Statistics and reproducibility. All the statistical analyses were performed with
GraphPad Prism or Analyse-it software. Details of statistical analyses can be found
in figure legends. Two-sided statistical analyses were performed on experiments
reproduced at least 3 times independently. The exact p values are indicated either
directly in the figure or in the legend. The exact sample size (n) is given in the
legend of each figure. The mean ± standard error of the mean (SEM) is displayed,
unless otherwise stated. Confidence interval was set to 95% in all statistical tests.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
The data generated or analyzed during this study are included in the article and
supplementary files. The transcriptomes of the 365 HCC biopsies analyzed in the current
study were obtained from The Cancer Genome Atlas (TCGA) database and are available
in Supplementary Data 1. The RNA-seq data for Huh7 and Huh7-GCK+/HK2− cell lines
are available in Supplementary Data 2 and at the Gene Expression Omnibus database
with the accession number GSE144214 for entire raw data. Source data and calculations
for all experiments can be found in Supplementary Data 4. Uncropped images of western
are provided in Supplementary Figs. 1 and 7.
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